If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
RHEUMATOLOGY
ISSN 2056-6395 Vol 2.1 • July 2015 • emjreviews.com
INSIDE
Review of
EULAR 2015
Rome, Italy
CONTENTS
EDITORIAL BOARD......................................................................................................................................... 4
CONGRESS REVIEW........................................................................................................................................ 10
• Review of the 16th EULAR Annual European Congress of Rheumatology, held in
Rome, Italy, 10th-13th June 2015
BEST ABSTRACT AWARD WINNERS AT EULAR 2015………………………................................................. 29
INTERVIEWS WITH EMJ RHEUMATOLOGY EDITORIAL BOARD AND AUTHORS........................... 36
SYMPOSIUM REVIEWS
• IL-17 INHIBITION: EMERGING PERSPECTIVES IN THE FUTURE MA
RHEUMATOLOGY ISSN 2056-6395
CONTENTS EDITORIAL BOARD.......................
RHEUMATOLOGY • OBESITY AND OSTEOARTHRITIS: MORE
Editorial Board Editor-in-Chief: Dr Ian Chik
Rheumatology Prof Gary Steven Gilkeson, P
European Medical Journal EMJ Rheumatology Vol 2
Welcome Hello, and a very warm welcome to this
The most accurate test for TB infection New Quant
Foreword
EULAR ANNUAL CONGRESS 2015 FIERA DI ROMA, ROME,
Welcome to the European Medical Journal review of
EULAR ANNUAL CONGRESS 2015 professionals, imp
H IGHLIGHTS Ultrasound Diagnosi
EULAR ANNUAL CONGRESS 2015 18 months using th
“Our data provide an argument for updating existi
EULAR ANNUAL CONGRESS 2015 “O
patients using anti-tumour necrosis factor t
EULAR ANNUAL CONGRESS 2015 “The findings from our
PsA occurs in 1-3% of the population and up to 30
EULAR ANNUAL CONGRESS 2015 “‘This Feeling!’ uses
Environmental Factors Increase Risk of Ankylosing
EULAR ANNUAL CONGRESS 2015 These results demonst
New Genetic Variants Linked with Autoinflammatory
EULAR ANNUAL CONGRESS 2015 to directly investi
other diseases,” said study investigator Dr Cécil
EULAR ANNUAL CONGRESS 2015 The benefits of DMARD
susceptible children aged 2-18 who were rec
EULAR ANNUAL CONGRESS 2015 patients in each grou
BEST ABSTRACT AWARD WINNERS AT EULAR 2015
EULAR ANNUAL CONGRESS 2015 patterns demonstrate
significance. Not only did the study identify
EULAR ANNUAL CONGRESS 2015 (i.e. undifferentiate
with an increased risk of primary SS (OR: 8.1, 95
EULAR ANNUAL CONGRESS 2015 Biologic agents hav
Would you like to write for the EMJ blog? Interac
I n Interview with P
SUBSCRIBE FREE TO OUR YOUTUBE CHANNEL www.youtube
INTERVIEWS Prodromos Sidiropoulos Associate Profe
Elaine Dennison Professor of Musculoskeletal Epid
INTERVIEWS and improve care for our pa
we were the first group to use a biologic
INTERVIEWS
defined in the community and many patients with in
INTERVIEWS A: My main research focus is in vascu
If you are interested in submitting a paper to
IL-17 INHIBITION: EMERGING PERSPECTIVES IN T
to other pathologies such as fractures, infection
immune tolerance) is mediated by iT cells.19 T
Approximately 25% of the genetic loci involved in
patients with AS and those with non-radiographic
Table 1: IL-17 blockade in human immune-mediated
of chronic back pain, indistinguishable from any
unmet needs and treatment challen
γt+ CD3+CD4-CD8- entheseal resident T cells. Nat
IL-17 INHIBITION IN SPONDYLOARTHRITIS: A
Peripheral arthritis Skin and nail disease Axia
Psoriatic Arthritis (MIPA) study26 showed
cells, whilst CD8+ cells predominate over CD4+ ce
IL-6/R inhibitors TNF inhibitors Adalimumab
inclusion of a 300 mg dose of secukinumab which g
few joints showed pencil-in-cup deformities and n
enthesitis, and bone erosion in PsA.IL-17 inhibit
31. Miossec P, Kolls JK. Targeting IL-17 and Th17
(Oxford). 2003;42(12):1469-76. 71. Torre Alonso J
EUROPEAN MEDICAL JOURNAL provides influential arti
PREGNANCY IN CHRONIC ARTHRITIS: ONLY A MATT
criteria,5 and almost 50% overall had at l
and experience with therapy often derives from co
Table 2 continued. Drug USA FDA risk category
LEF is a pyrimidine synthesis inhibitor tha
and infliximab (IFX), are considered Category B (T
Table 3: Practical points to consider when treati
rheumatoid arthritis during pregnancy: results
2008;26:854-9. 50. Vinet E et al. Biologic therap
OBESITY AND OSTEOARTHRITIS: MORE THAN JUST MECH
Obesity is rapidly becoming one of the world’s mo
Levels of leptin in synovial fluid also correlate
to date. The prohibitive cost of these agents is
OA exist. Current evidence suggests that IL
methylation in OA chondrocytes, as well as a role
REFERENCES 1. Cross M et al. The global burden o
resulting from intra-articular transforming growt
of print]. 82. Baker KR et al. Association of pla
DIFFUSE LARGE B CELL LYMPHOMA OF THE FOOT IN A
haematological malignancy. The patient was a
approximately 25% of all NHL in the develope
Patients with DLBCL typically present with a mass
lymphoma mimicking an articular relapse
DECIPHERING ECTOPIC CALCIFICATION: CONTRIBUTI
concentration (about 100-200 nmol/dm3) is finely r
by loss of function in the gene enc
in the ATP-binding cassette, subfamily C member 6
AB Figure 1: Skin alterations
in Abcc6 -/- transgenic mice,67,80 confirmed
in high-risk diabetic patients in the Diabet
in chronic kidney disease is induced by bone mor
cells from normal subjects and from Pseudoxa
AXIAL SPONDYLOARTHRITIS: AN EVOLVING CONCEPT
CLASSIFICATION OF AXIAL SPONDYLOARTHRITIS The t
Table 1: Comparison of the two main classification
cohort, where ASDAS correlated significantly with
Spine. 2014;81:197-9. 15. Robinson PC, Brown MA.
A UK BEST PRACTICE MODEL FOR DIAGNOSIS AND
Best practice for the care of people with AS’ in
METHODS Recruitment Between June 2010 and June 20
order to assist with managing flares, and early
RESULTS Referral Guidelines Between June 2010 and
No. ofPatients 60 50 40 30 20 10 0 New radio
using a standardised questionnaire. The authors a
of ankylosing spondylitis and related forms o
Buyer’s Guide • ABBVIE • ABIOGEN PHARMA S.P.
SUBSCRIBE TO RECEIVE THE LATEST CATIONS, & UPDA